Mi Ningning, Yang Man, Wei Lina, Nie Peng, Zhan Shukai, Nguyen Long H, Smith Fang Gao, Acharjee Animesh, Liu Xudong, Huang Junjie, Xia Bin, Yuan Jinqiu, Meng Wenbo
The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China.
Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Am J Gastroenterol. 2025 Jan 1;120(1):204-212. doi: 10.14309/ajg.0000000000003111. Epub 2024 Oct 4.
Gallstone diseases affect intestinal inflammation, bile flow, and gut microbiota, which in turn may increase the risk of inflammatory bowel disease (IBD). However, epidemiological studies exploring the associations between gallstone diseases and subsequent IBD risk have been limited.
This is a combined analysis of 3 prospective cohort studies (Nurses' Health Study, Nurses' Health Study II, and UK Biobank) and replicated in a case-control study (Chinese IBD Etiology Study). We evaluated the hazard ratios (HRs)/odds ratios (ORs) between gallstone diseases with IBD risk by Cox logistic regression or conditional logistic regression, adjusting for demographic characteristics, lifestyles, comorbidities, and medication usage.
We identified 3,480 cases of IBD over 2,127,471 person-years of follow-up in the 3 cohort studies. The participants with gallstone disease had a 38% increase in the risk of IBD (HR 1.38, 95% confidence intervals [CI] 1.21-1.59), 68% increase in Crohn's disease (HR 1.68, 95% CI 1.38-2.06), and 24% increase in ulcerative colitis (HR 1.24, 95% CI 1.03-1.49). In Chinese IBD Etiology Study, we found even larger magnitude of effects between gallstone diseases and IBD risk (IBD: OR 3.03, 95% CI 2.32-3.97; Crohn's disease: OR 5.31; 95% CI 3.71-7.60; ulcerative colitis: OR 1.49; 95% CI 1.07-2.06). There were no major differences in the estimated associations between the presence of unremoved gallstones and prior cholecystectomy with IBD risk.
Gallstone disease was linked to an increased risk of IBD and its subtypes, independent of traditional risk factors. Further research is needed to confirm these associations and clarify the underlying biological mechanisms.
胆结石疾病会影响肠道炎症、胆汁流动和肠道微生物群,进而可能增加炎症性肠病(IBD)的风险。然而,探索胆结石疾病与后续IBD风险之间关联的流行病学研究一直有限。
这是一项对3项前瞻性队列研究(护士健康研究、护士健康研究II和英国生物银行)的综合分析,并在一项病例对照研究(中国IBD病因研究)中进行了重复验证。我们通过Cox逻辑回归或条件逻辑回归评估胆结石疾病与IBD风险之间的风险比(HRs)/优势比(ORs),并对人口统计学特征、生活方式、合并症和药物使用情况进行了调整。
在3项队列研究中,经过2,127,471人年的随访,我们共识别出3480例IBD病例。患有胆结石疾病的参与者患IBD的风险增加了38%(HR 1.38,95%置信区间[CI] 1.21 - 1.59),患克罗恩病的风险增加了68%(HR 1.68,95% CI 1.38 - 2.06),患溃疡性结肠炎的风险增加了24%(HR 1.24,95% CI 1.03 - 1.49)。在中国IBD病因研究中,我们发现胆结石疾病与IBD风险之间的关联程度更大(IBD:OR 3.03,95% CI 2.32 - 3.97;克罗恩病:OR 5.31;95% CI 3.71 - 7.60;溃疡性结肠炎:OR 1.49;95% CI 1.07 - 2.06)。未取出胆结石的存在与先前胆囊切除术与IBD风险之间的估计关联没有重大差异。
胆结石疾病与IBD及其亚型风险增加有关,且独立于传统风险因素。需要进一步研究来证实这些关联并阐明潜在的生物学机制。